Collectively, our study highlights Gαi3’s multifaceted role in promoting pancreatic cancer growth through the modulation of Akt-mTOR and PKA-Hippo-YAP signaling pathways, as well as its influence on the immune landscape within the pancreatic cancer TME. The gene discussed is MTOR; the disease is familial pancreatic carcinoma.